Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cellular Analytics is developing a microfluidic platform technology to perform molecular characterization of cancer at the single circulating tumor cell level, aiming for rapid, accurate, and inexpensive diagnostics for cancer, with initial focus on lung cancer. The platform is designed to detect sensitivity to immune-oncology agents and to support precision medicine in oncology. There is no public evidence of therapeutic clinical results; activity is diagnostic/precision medicine focused at this stage and is not disclosed to be in clinical trials for therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cellular Analytics.